SEC Company Response from FILANA THERAPEUTICS, (FLNA) — Dec 3, 2025

FILANA THERAPEUTICS, INC.
Date: Dec. 3, 2025 · CIK: 0001069530 · Accession: 0001493152-25-025914

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-291489

Date

Dec. 3, 2025

Author

Form

CORRESP

Company

FILANA THERAPEUTICS, INC.

Letter

CASSAVA SCIENCES, INC.

N. Capital of Texas, Building 1

Suite

Austin, TX 78731

December 3, 2025

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F. Street, NE

Washington, DC 20549

Attn: Jessica Dickerson

Re: Cassava Sciences, Inc. Registration Statement No. 333-291489

Ladies and Gentlemen:

On behalf of Cassava Sciences, Inc. (the " Company "), the undersigned hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, that the effective time of the Registration Statement on Form S-3 (File No. 333-291489) filed on November 13, 2025 (the " Registration Statement ") be accelerated to 4:15 p.m., New York City time, on Friday, December 5, 2025, or as soon as practicable thereafter. The Company respectfully requests that you notify Peter E. Devlin of such effectiveness by a telephone call to (212) 326-3978.

Should you have any questions regarding the Registration Statement, please contact Peter E. Devlin at (212) 326-3978.

Thank you for your attention to this matter.

Sincerely,
CASSAVA SCIENCES, INC.

Show Raw Text

CORRESP
 1
 filename1.htm

 CASSAVA
SCIENCES, INC.

 6801
N. Capital of Texas, Building 1

 Suite
300

 Austin,
TX 78731

 December
3, 2025

 Via
EDGAR

 U.S.
Securities and Exchange Commission

 Division
of Corporation Finance

 100
F. Street, NE

 Washington,
DC 20549

 Attn:
Jessica Dickerson

 Re:
 Cassava
 Sciences, Inc. Registration Statement No. 333-291489

 Ladies
and Gentlemen:

 On
behalf of Cassava Sciences, Inc. (the " Company "), the undersigned hereby requests, pursuant to Rule 461 promulgated
under the Securities Act of 1933, that the effective time of the Registration Statement on Form S-3 (File No. 333-291489) filed on
November 13, 2025 (the " Registration Statement ") be accelerated to 4:15 p.m., New York City time, on Friday,
December 5, 2025, or as soon as practicable thereafter. The Company respectfully requests that you notify Peter E. Devlin of such
effectiveness by a telephone call to (212) 326-3978.

 Should
you have any questions regarding the Registration Statement, please contact Peter E. Devlin at (212) 326-3978.

 Thank
you for your attention to this matter.

 Sincerely,

 CASSAVA SCIENCES, INC.

 By:

 /s/
 Richard J. Barry

 Name:
 Richard
 J. Barry

 Title:
 President
 and Chief Executive Officer

 cc:
 Peter
 E. Devlin

 Ferrell
 M. Keel

 Jones
 Day

SecProbe.io